srch

At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve the lives of people with genomically defined diseases.

1 day ago · Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile,...

Mehrere gegen spezielle onkogene Treiber gerichtete Medikamente sind inzwischen zugelassen. Zwei davon stammen aus dem Hause Blueprint Medicines ...

Blueprint Medicines (Germany) GmbH, Munich, Germany Name Blueprint Medicines (Germany) GmbH Mondstein 420. GmbH Register Ut District Court of Munich HRB 245574 Address …

Blueprint Medicines (Germany) GmbH, München, Amtsgericht München HRB 245574: Netzwerk, Wirtschaftsinfos.

1 day ago · Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile,...

Die Blueprint Medicines (Germany) GmbH aus München ist im Register unter der Nummer HRB 245574 im Amtsgericht München verzeichnet. Sie ist mindestens 3x umgezogen seit der Gründung in 2018.

Die Blueprint Medicines (Germany) GmbH aus München ist im Register unter der Nummer HRB 245574 im Amtsgericht München verzeichnet. Sie ist mindestens 3x ...

Blueprint Medicines (Germany) GmbH mit Sitz in München ist im Handelsregister mit der Rechtsform Gesellschaft mit beschränkter Haftung ...

25.09.2019 · The visualizations for "Blueprint Medicines (Germany) GmbH - Name · Address · Managing Director: Jeffrey W. Albers, Michael Landsittel, Paul M. Beresford · No longer Managing Director: Antje Borcherdt · Corporate Purpose · Company statute" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

General Manager Germany. Vertex Pharmaceuticals. Jan. 2018 – Aug. 2019 1 Jahr 8 Monate. Munich Area, ...

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

1 dag siden · Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile,...

Blueprint Medicines (Switzerland) GmbH Baarerstrasse 8 6300 Zug Switzerland Patients, families and healthcare professionals For medical inquiries or questions about opportunities to participate in clinical trials: United States medinfo@blueprintmedicines.com 1-888-BLU-PRNT (1-888-258-7768) Europe medinfoeurope@blueprintmedicines.com +31 85 064 4001

Shares of Blueprint Medicines Corporation BPMC have rallied 24.8% in the past six months against the industry’s decrease of 18.7%. Image Source: Zacks Investment Research The company has made ...

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

4 timer siden · Blueprint Medicines' (BPMC) Ayvakit, approved to treat PDGFRA Exon 18 mutant gastrointestinal stromal tumors, has seen strong uptake since approval. Other pipeline candidates are also progressing ...

1 day ago · Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has successfully completed its previously announced acquisition of Lengo Therapeutics and lead compound LNG-451, a ...

Blueprint Medicines (Germany) GmbH, Munich, Germany, District Court of Munich HRB 245574: Network, Financial information.

Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic ...